Drawing for EFFLORASA

USPTO serial 85670031

EFFLORASA

Reviewed by CopyMark Law Group

Reg. 4325953Status 710
Filing date
Status date
Registration date
Apr 23, 2013
Examiner
VOHRA, SANJEEV KUMAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EFFLORASA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thaddius J. Carvis

THADDIUS J. CARVIS LAW OFFICES OF THADDIUS J. CARVIS102 N KING STLEESBURG, VA 20176-2821UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dietary and nutritional supplements containing hydrocolloids derived from plant sources; dietary and nutritional supplements used for weight loss; dietary supplements for humans in the forms of capsules and powders, to benefit lowering blood cholesterol and sugar levels and aiding weight lossSECTION 8 - CANCELLEDJan 11, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 29, 2019C8..CANCELLED SEC. 8 (6-YR)—
Apr 23, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 23, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 21, 2013SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 20, 2013REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Mar 19, 2013ALIEASSIGNED TO LIE—
Mar 5, 2013CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 28, 2013SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 28, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 13, 2013IUAFUSE AMENDMENT FILED—
Feb 13, 2013EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 29, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 4, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 4, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 14, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 30, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2012DOCKASSIGNED TO EXAMINER—
Jul 12, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance